{"id":"W2769634427","doi":"10.1177/2055217317743097","title":"A double-blind, placebo-controlled, single ascending-dose study of remyelinating antibody rHIgM22 in people with multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Acorda Therapeutics","keywords":"Tolerability; Placebo; Medicine; Pharmacodynamics; Pharmacokinetics; Multiple sclerosis; Adverse effect; Cohort; Internal medicine; Dosing; Biomarker; Pharmacology; Gastroenterology; Immunology; Pathology; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.002337933,0.00054835,0.00177754,0.0004097926,0.00134992,0.0003340965,0.0004665817,0.0002347176,0.000111461],"category_scores_gemma":[0.00106261,0.0004175294,0.0004889083,0.0002660327,0.0006841203,0.0007263858,0.0002313357,0.001147747,0.00000646501],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001465511,"about_ca_system_score_gemma":0.0001800408,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006649742,"about_ca_topic_score_gemma":0.00192748,"domain_scores_codex":[0.9941639,0.0004314932,0.002199806,0.0008669608,0.001610452,0.0007274269],"domain_scores_gemma":[0.9957994,0.00159671,0.001012877,0.0005893934,0.000431532,0.0005700673],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1082521,0.01031631,0.8021284,0.00005071472,0.0007348535,0.00003157714,0.00295956,0.0001050603,0.07169231,0.00001125292,0.00001387857,0.003703966],"study_design_scores_gemma":[0.267451,0.00346926,0.715957,0.0008927459,0.0001665605,0.00004361552,0.004492132,0.004145907,0.003035754,0.000006528426,0.00001225194,0.000327174],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942766,0.000735786,0.0001073532,0.00111389,0.0002706065,0.003116044,0.00003149125,0.00003759043,0.0003106801],"genre_scores_gemma":[0.9960234,0.0005968189,0.002533432,0.00004694395,0.0004460574,0.0002102303,0.00002616317,0.00007204467,0.0000449073],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1591989,"threshold_uncertainty_score":0.9999502,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2497445737129078,"score_gpt":0.4249105405719116,"score_spread":0.1751659668590039,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}